Gene Expression in Tumor Tissue From Women Undergoing Surgery for Breast Cancer or Core Biopsy of the Breast

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00898937
Recruitment Status : Terminated (Funding ended)
First Posted : May 12, 2009
Last Update Posted : July 19, 2017
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Georgetown University

Brief Summary:

RATIONALE: Studying samples of breast tissue in the laboratory may help doctors learn more about the genes and proteins found in breast tissue.

PURPOSE: This phase I trial is studying genes and proteins in breast tissue from women undergoing surgery for breast cancer or core biopsy of the breast.

Condition or disease Intervention/treatment
Breast Cancer Genetic: microarray analysis Procedure: breast biopsy

Detailed Description:


  • Assess tumor gene expression information from women undergoing surgery for breast cancer or core biopsy sampling of the breast.

OUTLINE: This is a pilot study.

Tumor tissue is collected and analyzed for tumor gene expression by DNA microarray analysis for research studies.

PROJECTED ACCRUAL: A total of 100 patients will be accrued for this study.

Study Type : Observational
Actual Enrollment : 100 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Pilot Study for Analysis of Tumor Gene Expression by DNA Microarray Analysis in Patients Undergoing Breast Cancer Surgery or Core Biopsy Sampling
Study Start Date : September 1999
Primary Completion Date : December 2014
Estimated Study Completion Date : December 2017

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Intervention Details:
    Genetic: microarray analysis
    tumor specimen will be assessed by microarray analysis
    Procedure: breast biopsy
    A breast biopsy will be done to obtain a tumor specimen

Primary Outcome Measures :
  1. Tumor gene expression as assessed by DNA microarray analysis [ Time Frame: 1 year ]
    tumor sample will be assessed by DNA microarray

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Any woman undergoing a breast biopsy or breast surgery


  • Undergoing surgery for breast cancer OR core biopsy sampling of the breast


  • Not specified


  • Not specified

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT00898937

United States, District of Columbia
Lombardi Comprehensive Cancer Center at Georgetown University Medical Center
Washington, D.C., District of Columbia, United States, 20007
Sponsors and Collaborators
Georgetown University
National Cancer Institute (NCI)
Principal Investigator: Claudine Isaacs, MD Lombardi Comprehensive Cancer Center

Responsible Party: Georgetown University Identifier: NCT00898937     History of Changes
Other Study ID Numbers: CDR0000377341
P50CA058185 ( U.S. NIH Grant/Contract )
P30CA051008 ( U.S. NIH Grant/Contract )
First Posted: May 12, 2009    Key Record Dates
Last Update Posted: July 19, 2017
Last Verified: February 2017

Keywords provided by Georgetown University:
breast cancer

Additional relevant MeSH terms:
Breast Neoplasms
Neoplasms by Site
Breast Diseases
Skin Diseases